ConductScience.org, home

Paper3967247

Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.

Rahman A and 3 others. Cancer Res, 1985. Cited by 91 papers, by iCite.

Cite this record

ConductScience Library. Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes. Papers, record 3967247. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3967247

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.
PubMed
Journal
Cancer Res
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
3.75
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rahman AA
2White GG
3More NN
4Schein PSP S

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CardiolipinsMajor topic
DoxorubicinMajor topic
LiposomesMajor topic
Animals
Bone Marrow
Kidney
Leukemia P388
Liver
Lung
Male
Mice
Mice, Inbred DBA
Microscopy, Electron
Myocardium
Spleen
Time Factors
Tissue Distribution

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA2P30 CA1-4626NCI NIH HHSUnited StatesPubMedPubMed
P30CA014626NIHNIH RePORTER

Download CSV of grants

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
24310494Nanotechnology and drug delivery: an update in oncology.Pharmaceutics2011https://conductscience.org/library/papers/24310494PubMed
23412283Hydroxycamptothecin liposomes inhibit collagen secretion and induce fibroblast apoptosis in a postlaminectomy rabbit model.Eur J Orthop Surg Traumatol2013https://conductscience.org/library/papers/23412283PubMed
18203425Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.Int J Nanomedicine2007https://conductscience.org/library/papers/18203425PubMed
8679456An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.Br J Cancer1996https://conductscience.org/library/papers/8679456PubMed
8500223Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8500223PubMed
8462124Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8462124PubMed
8194164Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8194164PubMed
7950152Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences.Clin Investig1994https://conductscience.org/library/papers/7950152PubMed
7642689Doxorubicin-heparin complex: reduction of cardiotoxicity of doxorubicin.J Cancer Res Clin Oncol1995https://conductscience.org/library/papers/7642689PubMed
7512899Anthracycline antibiotics in cancer therapy. Focus on drug resistance.Drugs1994https://conductscience.org/library/papers/7512899PubMed
7506649Liposomes as carriers of cancer chemotherapy. Current status and future prospects.Drugs1993https://conductscience.org/library/papers/7506649PubMed
3940217Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3940217PubMed
3527466Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3527466PubMed
3489480Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.Br J Cancer1986https://conductscience.org/library/papers/3489480PubMed
3484382Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3484382PubMed
3439799Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3439799PubMed
2791187A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2791187PubMed
2684010Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2684010PubMed
2491964Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2491964PubMed
1678995Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1678995PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3967247

GET https://conductscience.org/api/papers/v1/3967247/authors